Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Quince Therapeutics to Participate at Investor Events in January 2024


Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient's own biology to deliver rare disease therapeutics, today announced that Dirk Thye, M.D., Quince's Chief Executive Officer and Chief Medical Officer, will participate at two investor events taking place in San Francisco, California in January 2024:

About Quince Therapeutics

Quince Therapeutics (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the potential of a patient's own biology to deliver innovative and life-changing therapeutics to those living with rare diseases. For more information on the company and its latest news, visit www.quincetx.com and follow Quince Therapeutics on social media platforms LinkedIn, Facebook, and Twitter/X.


These press releases may also interest you

at 13:05
John Rich, a multi-platinum hit generator and music industry leader with a robust entrepreneurial and leadership resume will bring his passion and business acumen to Base Molecular Resonancetm Technologies, LLC (BMRT) as a shareholder and Strategic...

at 13:00
University Lab Partners (ULP), a premier nonprofit wet lab incubator located in Orange County, CA, has been chosen to lead the diagnostics and medical devices hub in the next generation of the BARDA Accelerator Network of the Biomedical Advanced...

at 13:00
Meet your daily step goals while supporting the region's military community at the second annual Run, Walk & Roll 5K on May 18 at Inland Empire Health Plan (IEHP)....

at 12:55
On Lok will host its annual On Lok Celebrates Friday, May 17th at Pier 27 in San Francisco. This year's theme, "The Blueprint of Senior Care," will honor On Lok's legacy of empowering Bay Area seniors to age at home with dignity and independence,...

at 12:53
CLn Skin Care, the innovative brand known for its breakthrough line of gentle yet effective cleansers for the face and body, today announces the appointment of two distinguished physician leaders to its esteemed medical advisory board (MAB) of the...

at 12:40
Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract research organization (CRO). This collaboration aims to assist South...



News published on and distributed by: